Improving heart rhythm treatment using advanced MRI techniques
Atrial fibrillation ablation assessment and guidance using native-contrast T1 weighted MRI
['FUNDING_R01'] · JOHNS HOPKINS UNIVERSITY · NIH-10881894
This study is looking at a new way to use MRI to help doctors better see the results of a heart procedure for atrial fibrillation, so patients can have safer and more effective treatments that reduce the chances of their heart rhythm problems coming back.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | JOHNS HOPKINS UNIVERSITY (nih funded) |
| Locations | 1 site (BALTIMORE, UNITED STATES) |
| Trial ID | NIH-10881894 on ClinicalTrials.gov |
What this research studies
This research focuses on enhancing the effectiveness of catheter ablation for atrial fibrillation (Afib), a common heart rhythm disorder. It aims to develop a non-contrast MRI method that can accurately identify permanent ablation lesions, which are crucial for successful treatment. By distinguishing between temporary and permanent tissue changes, the research seeks to improve the outcomes of the initial ablation procedure and reduce the recurrence of arrhythmias. Patients may benefit from more effective and safer treatment options for Afib.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with atrial fibrillation who are considering catheter ablation as a treatment option.
Not a fit: Patients with atrial fibrillation who are not candidates for catheter ablation or those who have already undergone multiple unsuccessful ablation procedures may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for atrial fibrillation, reducing the need for repeat procedures and improving patient outcomes.
How similar studies have performed: Previous research has shown promise in using advanced imaging techniques to improve outcomes in cardiac procedures, suggesting that this approach may also be effective.
Where this research is happening
BALTIMORE, UNITED STATES
- JOHNS HOPKINS UNIVERSITY — BALTIMORE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: KOLANDAIVELU, ARAVINDAN — JOHNS HOPKINS UNIVERSITY
- Study coordinator: KOLANDAIVELU, ARAVINDAN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.